...
首页> 外文期刊>Vascular pharmacology >Tetrahydrocurcumin in combination with deferiprone attenuates hypertension, vascular dysfunction, baroreflex dysfunction, and oxidative stress in iron-overloaded mice
【24h】

Tetrahydrocurcumin in combination with deferiprone attenuates hypertension, vascular dysfunction, baroreflex dysfunction, and oxidative stress in iron-overloaded mice

机译:四氢姜黄素与去铁酮合用可减轻铁超负荷小鼠的高血压,血管功能障碍,压力反射功能障碍和氧化应激

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Excessive iron can generate reactive oxygen species (ROS), leading to oxidative stress that is closely associated with cardiovascular dysfunction. Iron overload was induced in male ICR mice by injection of iron sucrose (10 mg/kg/day) for eight weeks. Iron overload was evidenced by increased serum iron indices. The mice developed increased blood pressure, impaired vascular function and blunted response of the autonomic nervous system. These effects were accompanied by increased malondialdehyde levels in various tissues, increased nitric oxide metabolites in plasma and urine, and decreased blood glutathione. Tetrahydrocurcumin (MU, 50 mg/kg/day), deferiprone (or L1, 50 mg/kg/day) or both was orally administered throughout the period of iron sucrose injection. The treatments significantly alleviated the deleterious cardiovascular effects of iron overload, and were associated with modulation of nitric oxide levels. An imbalance between endothelial nitric oxide synthase (eNOS) and inducible NOS (iNOS) expression in response to iron overload was normalized by THU, L1 or the combination treatment. Moreover, the treatment decreased the upregulated expression levels of gp91(phox), p47(phox) and HO-1. The combination of THU and L1 exerted a greater effect than THU or L1 monotherapy. These results suggest beneficial effects of THU and L1 on iron-induced oxidative stress, hypertension, and vascular dysfunction. (C) 2016 Elsevier Inc. All rights reserved.
机译:铁过多会产生活性氧(ROS),导致氧化应激,与心血管功能异常密切相关。通过注射蔗糖铁(10 mg / kg /天)八周,在雄性ICR小鼠中诱导铁超负荷。血清铁指数升高证明了铁超负荷。小鼠出现血压升高,血管功能受损和自主神经系统反应迟钝。这些影响伴随着各种组织中丙二醛水平的增加,血浆和尿液中一氧化氮代谢物的增加以及血液中谷胱甘肽的减少。在蔗糖铁注射期间,口服四氢姜黄素(MU,50 mg / kg /天),去铁酮(或L1,50 mg / kg /天)或两者口服。这些治疗显着减轻了铁超负荷的有害心血管作用,并且与一氧化氮水平的调节有关。通过THU,L1或联合治疗可以使内皮一氧化氮合酶(eNOS)和诱导型NOS(iNOS)表达之间的失衡归因于铁过载。此外,该治疗降低了gp91(phox),p47(phox)和HO-1的上调表达水平。与THU或L1单一疗法相比,THU和L1的组合发挥了更大的作用。这些结果表明,THU和L1对铁诱导的氧化应激,高血压和血管功能障碍具有有益作用。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号